Wen, S., Zeng, J., Zhong, L., Ye, J. and Lai, X. 2022. The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma: Nivolumab and lenvatinib in the treatment of HCC. Cellular and Molecular Biology. 68, 11 (Nov. 2022), 53–57. DOI:https://doi.org/10.14715/cmb/2022.68.11.10.